Nyt fra tidsskrifterne
Søgeord (rsv) valgt.
121 emner vises.
1
Community-Acquired Respiratory Virus Infections: A Threat to Long-Term survivors after Allogeneic Stem Cell Transplant?
Clinical Infectious Diseases
Tilføjet 6.12.2024
2
RSM01, a novel respiratory syncytial virus monoclonal antibody: preclinical characterization and results of a first-in-human, randomised clinical trial
BMC Infectious Diseases
Tilføjet 5.12.2024
3
Influence of COVID-19 public health restrictions on community-acquired pneumonia pathogens in children in Henan, China: a multicenter retrospective study
BMC Infectious Diseases
Tilføjet 5.12.2024
4
Lower respiratory tract infections following respiratory syncytial virus monoclonal antibody nirsevimab immunization versus placebo: Analysis from a Phase 3 randomized clinical trial (MELODY)
Clinical Infectious Diseases
Tilføjet 5.12.2024
5
Etiological analysis of acute respiratory infections in hospitalized children after the relaxation of COVID-19 non-pharmacological interventions in Quzhou, China
BMC Infectious Diseases
Tilføjet 30.11.2024
6
An Overview on Disease Burden and Management of Respiratory Syncytial Virus Infections in Older Adults in the Asia‐Pacific Region
Reviews in Medical Virology
Tilføjet 29.11.2024
7
A Phase 1b/2a Single Ascending Dose Study of a Half-life Extended RSV Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants
Journal of Infectious Diseases
Tilføjet 28.11.2024
8
Development of high titer anti-drug antibodies in a Phase 1b/2a infant clesrovimab trial are associated with RSV exposure beyond day 150
Journal of Infectious Diseases
Tilføjet 28.11.2024
9
Molecular characterization of human respiratory syncytial virus strains circulating among hospitalized children in Jordan
BMC Infectious Diseases
Tilføjet 27.11.2024
10
[Articles] Safety and immunogenicity of mRNA-1345 RSV vaccine coadministered with an influenza or COVID-19 vaccine in adults aged 50 years or older: an observer-blinded, placebo-controlled, randomised, phase 3 trial
Lancet Infectious Diseases
Tilføjet 26.11.2024
11
Evaluation of Immunoglobulin A Enzyme Immunoassays to Detect Primary Respiratory Syncytial Virus Infection in Infants and Young Children
Journal of Infectious Diseases
Tilføjet 25.11.2024
12
Cost of delivering childhood RSV prevention interventions to the health system in Kenya: a prospective analysis
BMJ Open
Tilføjet 23.11.2024
13
Epidemiological characteristics of five non-COVID respiratory viruses among 37,139 all-age patients during 2018 − 2023 in Weifang, China: a cross-sectional study
BMC Infectious Diseases
Tilføjet 21.11.2024
14
Systematic Review of the Efficacy and Safety of RSV‐Specific Monoclonal Antibodies and Antivirals in Development
Reviews in Medical Virology
Tilføjet 16.11.2024
15
Annual Clinical and Economic Burden of Medically Attended Lower Respiratory Tract Illnesses Due to Respiratory Syncytial Virus among US Infants Aged <12 Months
Journal of Infectious Diseases
Tilføjet 16.11.2024
16
What Is RSV Infection in Adults?
American Journal of Respiratory and Critical Care Medicine
Tilføjet 16.11.2024
17
Burden and seasonality of RSV bronchiolitis in hospitalized children on a French Caribbean island: Practical lessons from a 13‐year study
Journal of Medical Virology
Tilføjet 12.11.2024
18
Real-world use of multiplex point-of-care molecular testing or laboratory-based molecular testing for influenza-like illness in a 2021 to 2022 US outpatient sample
PLoS One Infectious Diseases
Tilføjet 12.11.2024
19
Hospital-based cross-sectional study on the clinical characteristics of children with severe acute respiratory infections in Hungary
BMC Infectious Diseases
Tilføjet 10.11.2024
20
Clinical characteristics and in-hospital outcomes associated with RSV-ALRI compared to other viral ALRI in hospitalised children under two years old
Journal of Infectious Diseases
Tilføjet 5.11.2024
21
Epidemiology of human metapneumovirus among children with severe or very severe pneumonia in high pneumonia burden settings: the PERCH study experience
Clinical Microbiology and Infection
Tilføjet 1.11.2024
22
[Health-care Development] Interactions between respiratory syncytial virus and Streptococcus pneumoniae in the pathogenesis of childhood respiratory infections: a systematic review
Lancet Respiratory Medicine
Tilføjet 30.10.2024
23
Mechanism of PRRSV infection and antiviral role of polyphenols
Virulence
Tilføjet 22.10.2024
24
[Articles] Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis
Lancet
Tilføjet 18.10.2024
25
RENOIR Trial — RSVpreF Vaccine Efficacy over Two Seasons
New England Journal of Medicine
Tilføjet 17.10.2024
26
[Articles] Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study
Lancet Infectious Diseases
Tilføjet 15.10.2024
27
Healthcare resource utilisation and costs in infants with confirmed respiratory syncytial virus infections: a national population cohort study
BMC Infectious Diseases
Tilføjet 14.10.2024
28
Cycles of susceptibility: Immunity debt explains altered infectious disease dynamics post -pandemic
Clinical Infectious Diseases
Tilføjet 11.10.2024
29
Comparative study on the epidemiological characteristics and hazards of respiratory syncytial virus and influenza virus infections among elderly people
BMC Infectious Diseases
Tilføjet 10.10.2024
30
Risk factors for severe respiratory syncytial virus-associated respiratory tract infection in a high HIV prevalence setting, South Africa, 2012 – 2018
BMC Infectious Diseases
Tilføjet 10.10.2024
31
Promising Top-Line Results for RSV Vaccine in Immunocompromised Adults
Journal of the American Medical Association
Tilføjet 6.10.2024
32
RSV Vaccine Effectiveness Against Hospitalization Among Older US Adults
Journal of the American Medical Association
Tilføjet 6.10.2024
33
Burden of disease and cost of illness of infants less than 6 months of age hospitalised with respiratory syncytial virus in Denmark – a 10-year national register-based study
BMC Infectious Diseases
Tilføjet 4.10.2024
34
Clinical and economic inpatient burden of respiratory syncytial virus (RSV) infections in children < 2 years of age in Germany, 2014–2019: a retrospective health claims analysis
Infection
Tilføjet 2.10.2024
35
[Spotlight] Louis Bont – leading efforts to find an RSV vaccine
Lancet Respiratory Medicine
Tilføjet 2.10.2024
36
[Series] Early-life respiratory syncytial virus disease and long-term respiratory health
Lancet Respiratory Medicine
Tilføjet 2.10.2024
37
[Series] Respiratory syncytial virus infections in adults: a narrative review
Lancet Respiratory Medicine
Tilføjet 2.10.2024
38
Prospective hospital-based cohort studies of Respiratory Syncytial Virus (RSV) infections in infants under one year during and after the SARS-CoV-2 pandemic in Japan
International Journal of Infectious Diseases
Tilføjet 28.09.2024
39
Viral etiology of febrile respiratory syndrome among patients in Liaoning Province, China
BMC Infectious Diseases
Tilføjet 28.09.2024
40
Creeping toward Effective Antiviral Agents for RSV Infection
New England Journal of Medicine
Tilføjet 27.09.2024
41
Comparison of characteristics of children hospitalized for respiratory syncytial virus infection during the pre- and post-COVID-19 eras: a multicenter retrospective study
BMC Infectious Diseases
Tilføjet 26.09.2024
42
[Review] The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access
Lancet Infectious Diseases
Tilføjet 24.09.2024
43
Genetic susceptibility to acute viral bronchiolitis
Journal of Infectious Diseases
Tilføjet 22.09.2024
44
[Series] Severe respiratory syncytial virus infection in children: burden, management, and emerging therapies
Lancet
Tilføjet 20.09.2024
45
[Series] Respiratory syncytial virus vaccination and immunoprophylaxis: realising the potential for protection of young children
Lancet
Tilføjet 20.09.2024
46
The severity of respiratory syncytial virus infection in children during the SARS-CoV-2/COVID-19 pandemic: A nationwide study of 11,915 cases in Germany
Infection
Tilføjet 13.09.2024
47
Modelling the potential clinical and economic impact of universal immunisation with nirsevimab versus standard of practice for protecting all neonates and infants in their first respiratory syncytial virus season in Spain
BMC Infectious Diseases
Tilføjet 7.09.2024
48
Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort study
International Journal of Infectious Diseases
Tilføjet 1.09.2024
49
Prenatal RSV Vaccine Not Tied to Higher Risk of Preterm Births
Journal of the American Medical Association
Tilføjet 31.08.2024
50
Co-detection of respiratory pathogens among ILI patients: characterization of samples collected during the 2018/19 and 2019/20 pre-pandemic seasons
BMC Infectious Diseases
Tilføjet 30.08.2024